Finland· FI-REL-REL46347
Rosudapin
A rosuvastatin und amlodipin product containing rosuvastatin calcium + amlodipine besylate, registered in Finland by KRKA d.d. Novo mesto. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin und amlodipin is registered in 5 of 19 countries.
Countries holding a registration under ATC C10BX09 (rosuvastatin und amlodipin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Rosuvastatin und amlodipin · ATC C10BX09
5 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- Italyprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Rosuvastatin calcium + Amlodipine besylate
- Manufacturer
- KRKA d.d. Novo mesto
- Country
- Finland (FI)
- ATC code
- C10BX09
- ATC class
- Rosuvastatin und Amlodipin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rosuvastatin und amlodipin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyCOAREDAMSCHARPER S.P.A.
- SpainROSUVASTATINA/AMLODIPINO ARISTO 10 MG/10 MG CAPSULAS DURASAristo Pharma Gmbh
- PolandRosuvastatin/Amlodipine TevaTeva B.V.
- GermanyRosuamlo ApontisAdamed Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Bulgaria · Тинтарос Ам
- Germany · Rosuamlo Apontis, Rosulod
- Spain · Rosuvastatina/Amlodipino Aristo
- Italy · Coaredam, Rosulod
- Poland · Rosuvastatin/Amlodipine Teva, Zahron Combi
- Portugal · Asutam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/baf1ecf3-0c76-4c91-a185-a7fd7cd5241b GET /v1/drugs/baf1ecf3-0c76-4c91-a185-a7fd7cd5241b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": null,
"strength": "10 mg / 5 mg",
"atc_label": "rosuvastatiini ja amlodipiini",
"ma_number": "32783",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL46347",
"authorised_at": "2016-01-29"
}See everything about rosuvastatin und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.